Neurobiology of Disease
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 6.0 | Q1 | 85.0% | 2.159 | Q1 | 95.9% |
| 2024 | 5.6 | Q1 | 87.3% | 2.009 | Q1 | 95.4% |
| 2023 | 5.1 | Q1 | 85.1% | 2.116 | Q1 | 95.9% |
| 2022 | 6.1 | Q1 | 84.9% | 1.893 | Q1 | 95.3% |
| 2021 | 7.0 | Q1 | 86.8% | 1.988 | Q1 | 95.9% |
| 2020 | — | — | 2.205 | Q1 | 96.2% | |
| 2019 | — | — | 2.285 | Q1 | 96.5% | |
| 2018 | — | — | 2.665 | Q1 | 97.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0969-9961
ISSN
1095-953X
country
UScoverage
1994-2026